2025-04-012026-03-312026-03-31false11387751BANNING DENTAL GROUP LTD2026-09-11falseiso4217:GBPxbrli:pure113877512025-03-31113877512026-03-31113877512025-04-012026-03-31113877512024-03-31113877512025-03-31113877512024-04-012025-03-3111387751bus:SmallEntities2025-04-012026-03-3111387751bus:AuditExempt-NoAccountantsReport2025-04-012026-03-3111387751bus:FullAccounts2025-04-012026-03-3111387751bus:PrivateLimitedCompanyLtd2025-04-012026-03-3111387751core:WithinOneYear2026-03-3111387751core:AfterOneYear2026-03-3111387751core:WithinOneYear2025-03-3111387751core:AfterOneYear2025-03-3111387751core:ShareCapital2026-03-3111387751core:SharePremium2026-03-3111387751core:RevaluationReserve2026-03-3111387751core:OtherReservesSubtotal2026-03-3111387751core:RetainedEarningsAccumulatedLosses2026-03-3111387751core:ShareCapital2025-03-3111387751core:SharePremium2025-03-3111387751core:RevaluationReserve2025-03-3111387751core:OtherReservesSubtotal2025-03-3111387751core:RetainedEarningsAccumulatedLosses2025-03-3111387751core:LandBuildings2026-03-3111387751core:PlantMachinery2026-03-3111387751core:Vehicles2026-03-3111387751core:FurnitureFittings2026-03-3111387751core:OfficeEquipment2026-03-3111387751core:NetGoodwill2026-03-3111387751core:IntangibleAssetsOtherThanGoodwill2026-03-3111387751core:ListedExchangeTraded2026-03-3111387751core:UnlistedNon-exchangeTraded2026-03-3111387751core:LandBuildings2025-03-3111387751core:PlantMachinery2025-03-3111387751core:Vehicles2025-03-3111387751core:FurnitureFittings2025-03-3111387751core:OfficeEquipment2025-03-3111387751core:NetGoodwill2025-03-3111387751core:IntangibleAssetsOtherThanGoodwill2025-03-3111387751core:ListedExchangeTraded2025-03-3111387751core:UnlistedNon-exchangeTraded2025-03-3111387751core:LandBuildings2025-04-012026-03-3111387751core:PlantMachinery2025-04-012026-03-3111387751core:Vehicles2025-04-012026-03-3111387751core:FurnitureFittings2025-04-012026-03-3111387751core:OfficeEquipment2025-04-012026-03-3111387751core:NetGoodwill2025-04-012026-03-3111387751core:IntangibleAssetsOtherThanGoodwill2025-04-012026-03-3111387751core:ListedExchangeTraded2025-04-012026-03-3111387751core:UnlistedNon-exchangeTraded2025-04-012026-03-3111387751core:MoreThanFiveYears2025-04-012026-03-3111387751core:Non-currentFinancialInstruments2026-03-3111387751core:Non-currentFinancialInstruments2025-03-3111387751dpl:CostSales2025-04-012026-03-3111387751dpl:DistributionCosts2025-04-012026-03-3111387751core:LandBuildings2025-04-012026-03-3111387751core:PlantMachinery2025-04-012026-03-3111387751core:Vehicles2025-04-012026-03-3111387751core:FurnitureFittings2025-04-012026-03-3111387751core:OfficeEquipment2025-04-012026-03-3111387751dpl:AdministrativeExpenses2025-04-012026-03-3111387751core:NetGoodwill2025-04-012026-03-3111387751core:IntangibleAssetsOtherThanGoodwill2025-04-012026-03-3111387751dpl:GroupUndertakings2025-04-012026-03-3111387751dpl:ParticipatingInterests2025-04-012026-03-3111387751dpl:GroupUndertakingscore:ListedExchangeTraded2025-04-012026-03-3111387751core:ListedExchangeTraded2025-04-012026-03-3111387751dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2025-04-012026-03-3111387751core:UnlistedNon-exchangeTraded2025-04-012026-03-3111387751dpl:CostSales2024-04-012025-03-3111387751dpl:DistributionCosts2024-04-012025-03-3111387751core:LandBuildings2024-04-012025-03-3111387751core:PlantMachinery2024-04-012025-03-3111387751core:Vehicles2024-04-012025-03-3111387751core:FurnitureFittings2024-04-012025-03-3111387751core:OfficeEquipment2024-04-012025-03-3111387751dpl:AdministrativeExpenses2024-04-012025-03-3111387751core:NetGoodwill2024-04-012025-03-3111387751core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3111387751dpl:GroupUndertakings2024-04-012025-03-3111387751dpl:ParticipatingInterests2024-04-012025-03-3111387751dpl:GroupUndertakingscore:ListedExchangeTraded2024-04-012025-03-3111387751core:ListedExchangeTraded2024-04-012025-03-3111387751dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-04-012025-03-3111387751core:UnlistedNon-exchangeTraded2024-04-012025-03-3111387751core:NetGoodwill2026-03-3111387751core:IntangibleAssetsOtherThanGoodwill2026-03-3111387751core:LandBuildings2026-03-3111387751core:PlantMachinery2026-03-3111387751core:Vehicles2026-03-3111387751core:FurnitureFittings2026-03-3111387751core:OfficeEquipment2026-03-3111387751core:AfterOneYear2026-03-3111387751core:WithinOneYear2026-03-3111387751core:ListedExchangeTraded2026-03-3111387751core:UnlistedNon-exchangeTraded2026-03-3111387751core:ShareCapital2026-03-3111387751core:SharePremium2026-03-3111387751core:RevaluationReserve2026-03-3111387751core:OtherReservesSubtotal2026-03-3111387751core:RetainedEarningsAccumulatedLosses2026-03-3111387751core:NetGoodwill2025-03-3111387751core:IntangibleAssetsOtherThanGoodwill2025-03-3111387751core:LandBuildings2025-03-3111387751core:PlantMachinery2025-03-3111387751core:Vehicles2025-03-3111387751core:FurnitureFittings2025-03-3111387751core:OfficeEquipment2025-03-3111387751core:AfterOneYear2025-03-3111387751core:WithinOneYear2025-03-3111387751core:ListedExchangeTraded2025-03-3111387751core:UnlistedNon-exchangeTraded2025-03-3111387751core:ShareCapital2025-03-3111387751core:SharePremium2025-03-3111387751core:RevaluationReserve2025-03-3111387751core:OtherReservesSubtotal2025-03-3111387751core:RetainedEarningsAccumulatedLosses2025-03-3111387751core:NetGoodwill2024-03-3111387751core:IntangibleAssetsOtherThanGoodwill2024-03-3111387751core:LandBuildings2024-03-3111387751core:PlantMachinery2024-03-3111387751core:Vehicles2024-03-3111387751core:FurnitureFittings2024-03-3111387751core:OfficeEquipment2024-03-3111387751core:AfterOneYear2024-03-3111387751core:WithinOneYear2024-03-3111387751core:ListedExchangeTraded2024-03-3111387751core:UnlistedNon-exchangeTraded2024-03-3111387751core:ShareCapital2024-03-3111387751core:SharePremium2024-03-3111387751core:RevaluationReserve2024-03-3111387751core:OtherReservesSubtotal2024-03-3111387751core:RetainedEarningsAccumulatedLosses2024-03-3111387751core:AfterOneYear2025-04-012026-03-3111387751core:WithinOneYear2025-04-012026-03-3111387751core:Non-currentFinancialInstrumentscore:CostValuation2025-04-012026-03-3111387751core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-04-012026-03-3111387751core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-04-012026-03-3111387751core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-04-012026-03-3111387751core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-04-012026-03-3111387751core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-04-012026-03-3111387751core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-04-012026-03-3111387751core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-04-012026-03-3111387751core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-04-012026-03-3111387751core:Non-currentFinancialInstrumentscore:CostValuation2026-03-3111387751core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2026-03-3111387751core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2026-03-3111387751core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2026-03-3111387751core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2026-03-3111387751core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2026-03-3111387751core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2026-03-3111387751core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2026-03-3111387751core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2026-03-3111387751core:Non-currentFinancialInstrumentscore:CostValuation2025-03-3111387751core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-03-3111387751core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-03-3111387751core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-03-3111387751core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-03-3111387751core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-03-3111387751core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-03-3111387751core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-03-3111387751core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-03-3111387751bus:Director12025-04-012026-03-3111387751bus:Director22025-04-012026-03-3111387751core:FurnitureFittingsToolsEquipment2025-03-3111387751core:FurnitureFittingsToolsEquipment2025-04-012026-03-3111387751core:FurnitureFittingsToolsEquipment2026-03-31

BANNING DENTAL GROUP LTD

Registered Number
11387751
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2026

BANNING DENTAL GROUP LTD
Company Information
for the year from 1 April 2025 to 31 March 2026

Directors

EYRUMLU, Azad, Dr
SHAKIR, Honar

Company Secretary

EYRUMLU, Azad, Dr

Registered Address

74 Pentland Road
Slough
SL2 1TN

Registered Number

11387751 (England and Wales)
BANNING DENTAL GROUP LTD
Balance Sheet as at
31 March 2026

Notes

2026

2025

£

£

£

£

Fixed assets
Intangible assets3225,208268,541
Tangible assets423,006159,946
Investments6830,400400
Investment property5600,000600,000
1,678,6141,028,887
Current assets
Stocks740,00089,211
Debtors9,380,9745,060,024
Cash at bank and on hand34,937207,992
9,455,9115,357,227
Creditors amounts falling due within one year8(10,977,275)(2,691,753)
Net current assets (liabilities)(1,521,364)2,665,474
Total assets less current liabilities157,2503,694,361
Creditors amounts falling due after one year9(1,238,313)(4,671,608)
Net assets(1,081,063)(977,247)
Capital and reserves
Called up share capital1,0001,000
Profit and loss account(1,082,063)(978,247)
Shareholders' funds(1,081,063)(977,247)
The financial statements were approved and authorised for issue by the Board of Directors on 11 September 2026, and are signed on its behalf by:
EYRUMLU, Azad, Dr
Director
SHAKIR, Honar
Director

Registered Company No. 11387751
BANNING DENTAL GROUP LTD
Notes to the Financial Statements
for the year ended 31 March 2026

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Functional and presentation currency
The financial statements are presented in sterling and this is the functional currency of the company.
Going concern
After reviewing the company's forecasts and projections, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis of accounting in preparing its financial statements.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover is reduced for estimated customer returns, rebates & other similar allowances.
Revenue from sale of goods
Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transition can be measured reliably.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Deferred tax
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Intangible assets
Intangible assets are stated at cost less accumulated amortisation and accumulated impairment losses. The assets are reviewed for impairment if the above factors indicate that the carrying amount may be impaired. Amortisation is included in 'administrative expenses' in the profit and loss account.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:

Straight line (years)
Plant and machinery4
Fixtures and fittings4
Vehicles4
Office Equipment4
Investments
Investments in subsidiaries, associates and joint ventures are measured at cost less any accumulated impairment losses. Listed investments are measured at fair value where the difference between cost and fair value is material. Unlisted investments are measured at fair value unless the value cannot be measured reliably, in which case they are measured at cost less any accumulated impairment losses. Changes in fair value are included in the profit and loss account.
Investment property
The investment property is accounted for under FRS 102, Section 16 Investment Property. Investment property is remeasured to fair value at each balance sheet date with fair value gains and losses being reported in profit or loss. Investment properties are valued using RICS open market valuation on a freehold basis.
Finance leases and hire purchase contracts
Assets held under finance leases which are leases where substantially all the risks and rewards of ownership of the asset have passed to the company, and hire purchase contracts are capitalised in the balance sheet. They are depreciated over the shorter of their useful lives or the term of the lease.
Stocks and work in progress
Stock is valued at the lower of cost and estimated selling price less costs to complete and sell. The cost methodology employed by the entity is the first-in first-out method. Estimated selling price less costs to complete and sell are derived from the selling price which the goods would fetch in an open market transaction with established customers less the costs expected to be incurred to enable the sale to complete. Provision is made for slow-moving and obsolete items of stock. Such provisions are recognised in profit or loss. Work in progress is valued using the percentage of completion method and values are calculated using the lower of cost and estimated selling price less costs to complete and sell. When stocks are sold, the carrying amount of those stocks is recognised as an expense within cost of sales. This takes place in the same period that the associated revenue is recognised.
Related parties
For the purposes of these financial statements, a related party could be a person or an entity. Careful consideration is given to the definition of a related party to ensure that all related party relationships, transactions and balances are identified.
2.Average number of employees

20262025
Average number of employees during the year02
3.Intangible assets

Goodwill

Other

Total

£££
Cost or valuation
At 01 April 25420,00013,332433,332
At 31 March 26420,00013,332433,332
Amortisation and impairment
At 01 April 25157,7107,081164,791
Charge for year41,9961,33743,333
At 31 March 26199,7068,418208,124
Net book value
At 31 March 26220,2944,914225,208
At 31 March 25262,2906,251268,541
4.Tangible fixed assets

Plant & machinery

Vehicles

Fixtures & fittings

Office Equipment

Total

£££££
Cost or valuation
At 01 April 25477,87432,890168,03235,129713,925
Additions--7,918-7,918
At 31 March 26477,87432,890175,95035,129721,843
Depreciation and impairment
At 01 April 25351,8458,222158,78335,129553,979
Charge for year119,4698,22217,167-144,858
At 31 March 26471,31416,444175,95035,129698,837
Net book value
At 31 March 266,56016,446--23,006
At 31 March 25126,02924,6689,249-159,946
5.Investment property

£
Fair value at 01 April 25600,000
At 31 March 26600,000
6.Fixed asset investments

Investments in groups1

Total

££
Cost or valuation
At 01 April 25400400
Additions830,000830,000
At 31 March 26830,400830,400
Net book value
At 31 March 26830,400830,400
At 31 March 25400400

Notes

1Investments in group undertakings and participating interests
7.Stocks

2026

2025

££
Other stocks40,00089,211
Total40,00089,211
8.Creditors: amounts due within one year

2026

2025

££
Trade creditors / trade payables939,252-
Amounts owed to related parties8,370,0261,465,707
Finance lease and HP contracts28,07429,979
Other creditors1,639,1741,196,067
Accrued liabilities and deferred income749-
Total10,977,2752,691,753
9.Creditors: amounts due after one year

2026

2025

££
Bank borrowings and overdrafts1,225,1994,633,753
Other creditors13,11437,855
Total1,238,3134,671,608
10.Obligations under finance leases

2026

2025

££
Finance lease and HP contracts41,18867,834
11.Related party transactions
The intercompany balances consist entirely of related party transactions, which form part of the ultimate controlling party. The accumulated balance as at year end, owed to the company is £1,656,327 (2025 - £2,406,860).
12.Controlling party
The ultimate controlling party is Steril Ltd.